Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters' Option to Purchase Additional Shares
Stock Information for Soleno Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.